| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66e061087b8b0ca4bda35df8e395be73 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2005-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4183c132e6ec5d6d9d30cb5ee1a5d486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26d2689b0c0e11ae4b92eeca598b9c16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dadc2f578f3dc0f1406a0a251dc95f10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ef85ac190256468742b88afb9af7f7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddcd6538ddfbe67b385ab8524e58f20f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cca02d05bf794e87584c7f47108e31e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b9e7ec6225f82bde045b3b7bef0cb40 |
| publicationDate |
2013-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-1984679-B |
| titleOfInvention |
Methods for preparing immunogenic conjugates |
| abstract |
The invention discloses methods for making an immunogenic conjugate that includes a hapten or an antigen covalently linked to a carrier. The methods include reacting a first agent with a dihydrazide resulting in a hydrazino-modified first agent, wherein the first agent is a hapten, an antigen or a carrier; reacting a second agent with a benzaldehyde compound resulting in a benzaldehyde-modified second agent, wherein the second agent is a hapten, an antigen or a carrier, provided that the first agent or the second agent is a carrier; and reacting the hydrazine-modified first agent with the benzaldehyde-modified second agent resulting in an immunogenic conjugate comprising a hapten or an antigen covalently linked to a carrier via a hydrazone linkage. |
| priorityDate |
2004-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |